Topics › Drug Policy › Ibogaine
Commentary by Gregory Ferenstein
Commentary by Gregory Ferenstein and Leonard Gilroy
Policy Brief by Gregory Ferenstein
Psychedelics Policy Newsletter by Gregory Ferenstein
Commentary by Gregory Ferenstein and Geoffrey Lawrence